Femme et Homme
- | Pays :
- Poland
- Finland
- Romania
- Les 11 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to: - demonstrate the efficacy of SR123781A in the prevention of venous thromboembolism (VTE) by the demonstration of a dose-response in patients undergoing total hip replacement surgery. The secondary objectives are to: - evaluate the safety of SR123781A in the prevention of VTE after elective total hip replacement surgery; and - to assess the SR123781A pharmacokinetic profile in patients undergoing elective total hip replacement surgery.
Critère d'inclusion
- Venous Thromboembolism